OPSONIX
Opsonix is developing and commercializing a pathogen-extracting therapy that uses its proprietary pathogen-capture proteins to remove infectious microbes and the toxins they release from circulating blood, offering a new broad-spectrum approach to transform the treatment of blood-borne infectious diseases, including sepsis.
OPSONIX
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.opsonixbio.com
Total Employee:
1+
Status:
Active
Contact:
617-444-8644
Email Addresses:
[email protected]
Total Funding:
9.25 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Founder
Investors List
Baxter Ventures
Baxter Ventures investment in Series A - Opsonix
